Biphasic Waveform Defibrillator Market Valued at $8.2 Billion in 2025, Set to Grow at a 7.0% CAGR

Biphasic waveform defibrillator market was valued at $8.2 billion in 2025 and is projected to reach $16.3 billion by 2035, growing at a CAGR of 7.0% during the forecast Period (2026-2035). Regulatory approvals enhance confidence in the safety and effectiveness of devices, promoting the adoption of biphasic waveform technology and driving market growth. This is exemplified by recent approvals that highlight the evolving capabilities and clinical reliability of modern defibrillators. For instance, in September?2025, the US Food and Drug Administration (FDA) granted premarket approval (PMA) for the ZOLL Zenix Monitor/Defibrillator, a professional EMS and hospital?grade device combining advanced monitoring with defibrillation capabilities, featuring an intuitive touchscreen and workflow automation designed to improve emergency cardiac care performance.

Browse the full report description of “Biphasic Waveform Defibrillator Market Size, Share & Trends Analysis by Product Type (Automated External Defibrillators (AEDs), Manual Defibrillators, Wearable Cardioverter Defibrillators (WCDs), and Implantable Cardioverter Defibrillators (ICDs)), By Technology (Analog Defibrillators, Digital Defibrillators, and Smart Defibrillators), By End?User (Hospitals, Ambulances, Home Care Settings, and Emergency Medical Services (EMS)), By Deployment Type (Fixed Defibrillators, and Portable Defibrillators), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/biphasic-waveform-defibrillator-market

Regulatory Approvals and Clinical Validation

• In May?2025, the FDA approved Element Science’s Jewel Patch Wearable Cardioverter Defibrillator, a wearable, non?invasive defibrillation system intended for patients with temporary elevated risk of sudden cardiac arrest, offering a low?profile alternative to conventional defibrillators.
• In April?2025, the FDA clearance of Medtronic’s OmniaSecure defibrillation lead for implantable defibrillators supports improvements in defibrillation system design by enabling a smaller, catheter?based lead for delivering therapy within the heart.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Technology
  • By End?User
  • By Deployment Type
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Koninklijke Philips N.V., Medtronic plc , Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corp.ZOLL Medical Corp.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biphasic Waveform Defibrillator Market Report Segment

By Product Type

• Automated External Defibrillators (AEDs)
• Manual Defibrillators
• Wearable Cardioverter Defibrillators (WCDs)
• Implantable Cardioverter Defibrillators (ICDs)

By Technology

• Analog Defibrillators
• Digital Defibrillators
• Smart Defibrillators

By End?User

• Hospitals
• Ambulances
• Home Care Settings
• Emergency Medical Services (EMS)

By Deployment Type

• Fixed Defibrillators
• Portable Defibrillators

Global Biphasic Waveform Defibrillator Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biphasic-waveform-defibrillator-market